Human iPSC-based modeling of late-onset disease via progerin-induced aging

Cited by (783)

Items 101–200 of 783

1. Three‐Dimensional Models of the Human Brain Development and Diseases
   Mehdi Jorfi, Carla D’Avanzo, Doo Yeon Kim, Daniel Irimia · 2017 · Advanced Healthcare Materials
2. Human iPSC-Derived Neural Models for Studying Alzheimer’s Disease: from Neural Stem Cells to Cerebral Organoids
   Martin Barák, Veronika Fedorová, Veronika Pospíšilová, Jan Raška, Simona Vochyánová, Jiří Sedmík, Hana Hříbková, Hana Klímová, Tereza Váňová, Dáša Bohačiaková · 2022 · Stem Cell Reviews and Reports
3. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation
   Elisa Giacomelli, Björn Friedhelm Vahsen, Elizabeth L. Calder, Yinyan Xu, Jakub Scaber, Elizabeth Gray, Ruxandra Dafinca, Kevin Talbot, Lorenz Studer · 2022 · Cell stem cell
4. Age-related Huntington’s disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy
   Oh, Young Mi, Lee, Seong Won, Kim, Woo Kyung, Chen, Shawei, Church, Victoria A., Cates, Kitra, Li, Tiandao, Zhang, Bo, Dolle, Roland E., Dahiya, Sonika et al. · 2022 · Nature Neuroscience
5. Rapid, efficient, and simple motor neuron differentiation from human pluripotent stem cells
   Shimojo, Daisuke, Onodera, Kazunari, Doi-Torii, Yukiko, Ishihara, Yasuharu, Hattori, Chinatsu, Miwa, Yukino, Tanaka, Satoshi, Okada, Rina, Ohyama, Manabu, Shoji, Masanobu et al. · 2015 · Molecular Brain
6. NF-κB activation impairs somatic cell reprogramming in ageing
   Clara Soria‐Valles, Fernando G. Osorio, Ana Gutiérrez‐Fernández, Alejandro De Los Angeles, Clara Bueno, Pablo R. Menéndez, José Ignacio Martín-Subero, George Q. Daley, José M.P. Freije, Carlos López-Otı́n · 2015 · Nature Cell Biology · Retracted
7. Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
   Anna M. Speicher, Heinz Wiendl, Sven Guenther Meuth, Matthias Pawlowski · 2019 · Molecular Neurodegeneration
8. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders
   Rachel M. Wise, Annika Wagener, Urban M. Fietzek, Thomas Klopstock, Eugene V. Mosharov, Fabio Andrea Zucca, David L. Sulzer, Luigi Zecca, Lena F. Burbulla · 2022 · Neurobiology of Disease
9. Proteostasis and lysosomal repair deficits in transdifferentiated neurons of Alzheimer’s disease
   Chou, Ching-Chieh, Vest, Ryan, Prado, Miguel A., Wilson-Grady, Joshua, Paulo, Joao A., Shibuya, Yohei, Moran-Losada, Patricia, Lee, Ting-Ting, Luo, Jian, Gygi, Steven P. et al. · 2025 · Nature Cell Biology
10. Application of biomaterials to advance induced pluripotent stem cell research and therapy
    Zhi-Xiang Tong, Aniruddh Solanki, Allison E. Hamilos, O. Levy, Ke Wen, Xiaolei Yin, J. Karp · 2015 · EMBO Journal
11. Modeling neurological diseases using iPSC-derived neural cells: iPSC modeling of neurological diseases
    Li, Li, Chao, Jianfei, Shi, Yanhong · 2018 · Cell and Tissue Research
12. Opportunities for organoids as new models of aging
    Jennifer L. Hu, Michael E. Todhunter, Mark A. LaBarge, Zev J. Gartner · 2017 · The Journal of Cell Biology
13. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome
    Zeming Wu, Weiqi Zhang, Moshi Song, Wei Wang, Gang Wei, Wei Li, Jinghui Lei, Yu Huang, Yanmei Sang, Piu Chan et al. · 2018 · Protein & Cell
14. Decoding the relationship between ageing and amyotrophic lateral sclerosis: a cellular perspective
    Virenkumar A. Pandya, Rickie Patani · 2019 · Brain
15. Innovations in 3D Tissue Models of Human Brain Physiology and Diseases
    Michael L. Lovett, Thomas J.F. Nieland, Yu‐Ting L. Dingle, David Lee Kaplan · 2020 · Advanced Functional Materials
16. Modeling psychiatric disorders: from genomic findings to cellular phenotypes
    Anna Falk, Vivi Majella Heine, Adrian J. Harwood, Patrick F. Sullivan, Michael Peitz, Oliver Brüstle, Sanbing Shen, Y-M Sun, Joel Clinton Glover, Daniëlle Posthuma et al. · 2016 · Molecular Psychiatry
17. The epichaperome is a mediator of toxic hippocampal stress and leads to protein connectivity-based dysfunction
    Maria Carmen Inda, Suhasini Joshi, Tai Wang, Alexander Bolaender, Srinivasa R. Gandu, John Koren, Alicia Yue, Tony Taldone, Pengrong Yan, Weilin Sun et al. · 2020 · Nature Communications
18. Declining lamin B1 expression mediates age-dependent decreases of hippocampal stem cell activity
    bin Imtiaz, Muhammad Khadeesh, Jaeger, Baptiste N., Bottes, Sara, Machado, Raquel A.C., Vidmar, Mojca, Moore, Darcie L., Jessberger, Sebastian · 2021 · Cell Stem Cell
19. Human pluripotent stem cell–derived models and drug screening in CNS precision medicine
    M. Catarina Silva, Stephen J. Haggarty · 2019 · Annals of the New York Academy of Sciences
20. Midbrain Organoids: A New Tool to Investigate Parkinson’s Disease
    Lisa M. Smits, Jens Christian Schwamborn · 2020 · Frontiers in Cell and Developmental Biology
21. Human neuronal maturation comes of age: cellular mechanisms and species differences
    Wallace, Jenelle L., Pollen, Alex A. · 2024 · Nature Reviews Neuroscience
22. Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases
    Kelly M. Haston, Steven M. Finkbeiner · 2015 · The Annual Review of Pharmacology and Toxicology
23. Organoid Models of Glioblastoma and Their Role in Drug Discovery
    Matthew J. Rybin, Michael E. Ivan, Nagi G. Ayad, Zane R. Zeier · 2021 · Frontiers in Cellular Neuroscience
24. Establishment of human iPSC-based models for the study and targeting of glioma initiating cells
    Ignacio Sancho-Martinez, Emmanuel Nivet, Yun Fei Xia, Tomoaki Hishida, Aitor Aguirre, Alejandro Ocampo, Li Ma, Robert E. Morey, Marie N. Krause, Andreas Zembrzycki et al. · 2016 · Nature Communications
25. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
    Hawrot, James, Imhof, Sophie, Wainger, Brian J. · 2020 · Neurobiology of Disease
26. Limitations of human brain organoids to study neurodegenerative diseases: a manual to survive
    Urrestizala-Arenaza, Nerea, Cerchio, Sonia, Cavaliere, Fabio, Magliaro, Chiara · 2024 · Frontiers in Cellular Neuroscience
27. Creating Patient-Specific Neural Cells for the In Vitro Study of Brain Disorders
    Kristen Brennand, Maria Carolina Marchetto, Nissim Benvenisty, Oliver Brüstle, Allison D. Ebert, Juan Carlos Izpisúa Belmonte, Ajamete Kaykas, Madeline A. Lancaster, Frederick J. Livesey, Michael J. McConnell et al. · 2015 · Stem Cell Reports
28. Brief Report: Isogenic Induced Pluripotent Stem Cell Lines From an Adult With Mosaic Down Syndrome Model Accelerated Neuronal Ageing and Neurodegeneration
    Murray, Aoife, Letourneau, Audrey, Canzonetta, Claudia, Stathaki, Elisavet, Gimelli, Stefania, Sloan-Bena, Frederique, Abrehart, Robert, Goh, Pollyanna, Lim, Shuhui, Baldo, Chiara et al. · 2015 · Stem Cells
29. Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities
    Francesca Pistollato, Elan Liss Ohayon, Ann Lam, Gillian R. Langley, Thomas J. Novak, David Pamies, George L. Perry, Eugenia V. Trushina, Robin S. B. Williams, Alex E. Roher et al. · 2016 · Oncotarget
30. Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming
    Sun, Zhao, Kwon, Ji-Sun, Ren, Yudong, Chen, Shawei, Walker, Courtney K., Lu, Xinguo, Cates, Kitra, Karahan, Hande, Sviben, Sanja, Fitzpatrick, James A. J. et al. · 2024 · Science
31. Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective
    Pierre Cau, Claire Laure Navarro, Karim Harhouri, Patrice Roll, Sabine Sigaudy, Élise Kaspi, Sophie Perrin, Annachiara De Sandre‐Giovannoli, Nicolas Lévy · 2014 · Seminars in Cell and Developmental Biology
32. Vitamin C alleviates aging defects in a stem cell model for Werner syndrome
    Ying Li, Weizhou Zhang, Liang Chang, Yan Han, Liang Sun, Xiaojun Gong, Hong Tang, Zunpeng Liu, Huichao Deng, Yanxia Ye et al. · 2016 · Protein & Cell
33. An Induced Pluripotent Stem Cell Patient Specific Model of Complement Factor H (Y402H) Polymorphism Displays Characteristic Features of Age-Related Macular Degeneration and Indicates a Beneficial Role for UV Light Exposure
    Hallam, Dean, Collin, Joseph, Bojic, Sanja, Chichagova, Valeria, Buskin, Adriana, Xu, Yaobo, Lafage, Lucia, Otten, Elsje. G., Anyfantis, George, Mellough, Carla et al. · 2017 · Stem Cells
34. Dysregulation of the autophagic-lysosomal pathway in Gaucher and Parkinson's disease
    Pitcairn, Caleb, Wani, Willayat Yousuf, Mazzulli, Joseph R. · 2019 · Neurobiology of Disease
35. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease
    Yi‐Ying Wu, Feng‐Lan Chiu, Chan-Shien Yeh, Hung‐Chih Kuo · 2019 · Open Biology
36. Stem Cells of the Aging Brain
    A. Nicaise, Cory M. Willis, S. Crocker, S. Pluchino · 2020 · Frontiers in Aging Neuroscience
37. Toward stem cell-based phenotypic screens for neurodegenerative diseases
    Vikram Khurana, Daniel F. Tardiff, Chee Yeun Chung, Susan Lee Lindquist · 2015 · Nature Reviews Neurology
38. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond
    Britta Vallazza, Sebastian Petri, Marco A. Poleganov, Florian Eberle, Andreas N. Kuhn, Uğur Şahin · 2015 · Wiley Interdisciplinary Reviews - RNA
39. Escape from Pluripotency via Inhibition of TGF-β/BMP and Activation of Wnt Signaling Accelerates Differentiation and Aging in hPSC Progeny Cells
    Koki Fujimori, Takuya Matsumoto, Fumihiko Kisa, Nobutaka Hattori, Hideyuki Okano, Wado Akamatsu · 2017 · Stem Cell Reports
40. The mechanistic role of alpha-synuclein in the nucleus: impaired nuclear function caused by familial Parkinson’s disease SNCA mutations
    Vivian Chen, Malik Moncalvo, Dominic Tringali, Lidia Tagliafierro, Ahila Sriskanda, Ekaterina Ilich, Wendy Dong, Boris Kantor, Ornit Chiba‐Falek · 2020 · Human Molecular Genetics
41. Age Is Relative—Impact of Donor Age on Induced Pluripotent Stem Cell-Derived Cell Functionality
    Elisabeth Tamara Strässler, Katriina Aalto‐Setälä, Mostafa Kiamehr, Ulf Landmesser, Nicolle Kränkel · 2018 · Frontiers in Cardiovascular Medicine
42. Induced pluripotent stem cells: a tool for modeling Parkinson’s disease
    Anindita Bose, Gregory A. Petsko, Lorenz Studer · 2022 · Trends in Neurosciences
43. Advanced human iPSC-based preclinical model for Parkinson’s disease with optogenetic alpha-synuclein aggregation
    Min Seong Kim, Eun A. Ra, Sin Ho Kweon, Bo Am Seo, Han Seok Ko, Yohan Oh, Gabsang Lee · 2023 · Cell stem cell
44. A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses
    Marcela K. Preininger, Rajneesh Jha, Joshua T. Maxwell, Qingling Wu, Monalisa Singh, Bo Wang, Aarti S Dalal, Zachary T. McEachin, Wilfried Rossoll, Chadwick M. Hales et al. · 2016 · Disease Models & Mechanisms
45. A Simplified Method for Generating Purkinje Cells from Human-Induced Pluripotent Stem Cells
    Lauren M. Watson, Maggie M. K. Wong, Jane Vowles, Sally A. Cowley, Esther B. E. Becker · 2018 · The Cerebellum
46. Deconstructing Stepwise Fate Conversion of Human Fibroblasts to Neurons by MicroRNAs
    Cates, Kitra, McCoy, Matthew J., Kwon, Ji-Sun, Liu, Yangjian, Abernathy, Daniel G., Zhang, Bo, Liu, Shaopeng, Gontarz, Paul, Kim, Woo Kyung, Chen, Shawei et al. · 2021 · Cell Stem Cell
47. Cellular models as tools for the study of the role of alpha-synuclein in Parkinson's disease
    Diana F. Lázaro, Maria Angeliki S. Pavlou, Tiago F. Outeiro · 2017 · Experimental Neurology
48. New considerations for hiPSC-based models of neuropsychiatric disorders
    Gabriel E. Hoffman, Nadine Schrode, Erin K. Flaherty, Kristen Brennand · 2018 · Molecular Psychiatry
49. Induced pluripotent stem cells from ALS patients for disease modeling
    Jean‐Philippe Richard, Nicholas John Maragakis · 2014 · Brain Research
50. Pluripotent stem cell-based disease modeling: current hurdles and future promise
    Nadja Zeltner, Lorenz Studer · 2015 · Current Opinion in Cell Biology
51. Capturing the biology of disease severity in a PSC-based model of familial dysautonomia
    Nadja Zeltner, Faranak Fattahi, Nicole C. Dubois, Nathalie G. Saurat, Fabien G. Lafaille, Lei Shang, Bastian Zimmer, Jason H. Tchieu, Mohamed A. Soliman, Gabsang Lee et al. · 2016 · Nature Medicine
52. Current Advances and Limitations in Modeling ALS/FTD in a Dish Using Induced Pluripotent Stem Cells
    Wenting Guo, Laura Fumagalli, Robert Ciarán Prior, Ludo Van Den Bosch · 2017 · Frontiers in Neuroscience
53. Stem cell derived oligodendrocytes to study myelin diseases
    Chanoumidou, Konstantina, Mozafari, Sabah, Baron‐Van Evercooren, Anne, Kuhlmann, Tanja · 2020 · Glia
54. Human Organoids for the Study of Retinal Development and Disease
    Claire M. Bell, Donald J. Zack, Cynthia A. Berlinicke · 2020 · Annual Review of Vision Science
55. Induced pluripotent stem cells in Parkinson's disease: scientific and clinical challenges
    Bin Xiao, Huck‐Hui Ng, Ryōsuke Takahashi, Eng-King Tan · 2016 · Journal of Neurology Neurosurgery & Psychiatry
56. Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms
    Angélica María Sabogal-Guáqueta, Alejandro Marmolejo-Garza, Vítor Passos de Pádua, Bart J. L. Eggen, Erik Boddeke, Amalia M. Dolga · 2020 · Progress in Neurobiology
57. Do not keep it simple: recent advances in the generation of complex organoids
    Philipp Wörsdörfer, Takashi Ito, Izumi Asahina, Yoshinori Sumita, Süleyman Ergün · 2020 · Journal of Neural Transmission
58. Using iPS Cells toward the Understanding of Parkinson’s Disease
    Roger Torrent, Francesca Rigotti, Patrizia Dell’Era, Maurizio Memo, Ángel Raya, Antonella Consiglio · 2015 · Journal of Clinical Medicine
59. iPSC technology-Powerful hand for disease modeling and therapeutic screen
    Chang‐Sung Kim · 2015 · BMB Reports
60. A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation
    Chao Sheng, Johannes Jungverdorben, Hendrik Wiethoff, Qiong Lin, Lea Jessica Flitsch, Daniela Eckert, Matthias Hebisch, Julia Fischer, Jaideep Kesavan, Beatrice Weykopf et al. · 2018 · Nature Communications
61. Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease.
    Gatto, Noemi, Dos Santos Souza, Cleide, Shaw, Allan C., Bell, Simon M., Myszczynska, Monika A., Powers, Samantha, Meyer, Kathrin, Castelli, Lydia M., Karyka, Evangelia, Mortiboys, Heather et al. · 2021 · Aging Cell
62. Genome-wide CRISPR screen identifies neddylation as a regulator of neuronal aging and AD neurodegeneration
    Nathalie G. Saurat, Andrew P. Minotti, Maliha T. Rahman, Trisha Sikder, Chao Zhang, Daniela Cornacchia, Johannes Jungverdorben, Gabriele Ciceri, Doron Betel, Lorenz Studer · 2024 · Cell stem cell
63. Prevention of the degeneration of human dopaminergic neurons in an astrocyte co‐culture system allowing endogenous drug metabolism
    Liudmila V. Efremova, Stefan Schildknecht, Martina Adam, Regina Pape, Simon Gutbier, Benjamin Hanf, Alexander Bürkle, Marcel Leist · 2015 · British Journal of Pharmacology
64. Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies
    Maciej Daniszewski, Duncan E. Crombie, Rachael Henderson, Helena Hai Liang, Raymond C.B. Wong, Alex William Hewitt, Alice Pébay · 2017 · SLAS TECHNOLOGY
65. Stem Cells on the Brain: Modeling Neurodevelopmental and Neurodegenerative Diseases Using Human Induced Pluripotent Stem Cells
    Priya Srikanth, Tracy L. Young‐Pearse · 2014 · Journal of Neurogenetics
66. Using stem cell–derived neurons in drug screening for neurological diseases
    Daniel Little, Robin Ketteler, Paul Gissen, Michael J. Devine · 2019 · Neurobiology of Aging
67. Modeling neurodegenerative diseases with cerebral organoids and other three-dimensional culture systems: focus on Alzheimer’s disease
    Lalitha Venkataraman, Summer Rose Fair, Craig A. McElroy, Mark E. Hester, Hongjun Fu · 2020 · Stem Cell Reviews and Reports
68. Back and forth in time: Directing age in iPSC-derived lineages
    Cornacchia, Daniela, Studer, Lorenz · 2017 · Brain Research
69. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models
    Stephen J. Haggarty, M. Catarina Silva, Alan J. Cross, Nicholas J. Brandon, Roy H. Perlis · 2016 · Molecular and Cellular Neuroscience
70. Next‐generation disease modeling with direct conversion: a new path to old neurons
    Larissa Traxler, Frank Edenhofer, Jérôme Mertens · 2019 · FEBS Letters
71. Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
    Giovanna Cenini, Matthias Hebisch, Vira Iefremova, Lea Jessica Flitsch, Yannik Breitkreuz, Rudolph E. Tanzi, Doo Yeon Kim, Michael Peitz, Oliver Brüstle · 2020 · Molecular and Cellular Neuroscience
72. Transient inhibition of p53 enhances prime editing and cytosine base-editing efficiencies in human pluripotent stem cells
    Mu Li, Aaron Zhong, Youjun Wu, Mega Sidharta, Michael W. Beaury, Xiaolan Zhao, Lorenz Studer, Ting Zhou · 2022 · Nature Communications
73. Probing the missing mature β-cell proteomic landscape in differentiating patient iPSC-derived cells
    Heidrun Vethe, Yngvild Bjørlykke, Luiza Ghila, João A. Paulo, Hanne Scholz, Steven P. Gygi, Simona Chera, Helge Ræder · 2017 · Scientific Reports
74. Emerging Brain‐Pathophysiology‐Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains‐on‐a‐Chip
    Seokyoung Bang, Songhyun Lee, Nakwon Choi, Hong Nam Kim · 2021 · Advanced Healthcare Materials
75. Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease
    Karolina Pircs, Janelle Drouin‐Ouellet, Vivien Horváth, Jeovanis Gil, Melinda Rezeli, Raquel Garza, Daniela A. Grassi, Yogita Sharma, Isabelle St‐Amour, Kate L. Harris et al. · 2021 · Brain
76. Untitled work
    2023 · 10.1016/j.celrep.2023.112593
77. Type I IFN drives unconventional IL-1β secretion in lupus monocytes
    Simone Caielli, Preetha Balasubramanian, Juan F. Rodríguez-Alcázar, Uthra Balaji, Lauren A. Robinson, Zurong Wan, Jeanine M. Baisch, Cynthia Smitherman, Lynnette Walters, Paola R. Sparagana et al. · 2024 · Immunity
78. Prelamin A accumulation and stress conditions induce impaired Oct-1 activity and autophagy in prematurely aged human mesenchymal stem cell
    Arantza Infante, Andrea Gago, Garbiñe Ruiz de Eguino, Teresa Calvo-Fernández, Vanessa Gómez‐Vallejo, Jordi Llop, Karin Schlangen, Ane Fullaondo, Ana María Aransay, Abraham Martín et al. · 2014 · Aging
79. HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons
    Sarah Kishinevsky, Tai Wang, Anna Rodina, Sun Young Chung, Chao Xu, John Philip, Tony Taldone, Suhasini Joshi, Mary L. Alpaugh, Alexander Bolaender et al. · 2018 · Nature Communications
80. Accelerating neuronal aging in in vitro model brain disorders: a focus on reactive oxygen species
    Priscila Britto Campos, Bruna S. Paulsen, Stevens Kastrup Rehen · 2014 · Frontiers in Aging Neuroscience
81. Single-cell RNA-seq reveals dynamic transcriptome profiling in human early neural differentiation
    Zhouchun Shang, Dongsheng Chen, Quanlei Wang, Shengpeng Wang, Qiuting Deng, Liang Li Wu, Chuanyu Liu, Xiangning Ding, Shiyou Wang, Jixing Zhong et al. · 2018 · GigaScience
82. Neuronal Senescence in the Aged Brain
    Shu-Min Chou, Yu‐Hsin Yen, Fang Yuan, Su‐Chun Zhang, Cheong‐Meng Chong · 2023 · Aging and Disease
83. Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease
    Sullivan, Sarah E., Young-Pearse, Tracy L. · 2017 · Brain Research
84. Probing disorders of the nervous system using reprogramming approaches
    Justin K. Ichida, Evangelos Kiskinis · 2015 · The EMBO Journal
85. Messenger RNAs localized to distal projections of human stem cell derived neurons
    Rebecca L. Bigler, Joyce W. Kamande, ‎Raluca Dumitru, Mark S. Niedringhaus, Anne Marion Taylor · 2017 · Scientific Reports
86. FGF Modulates the Axial Identity of Trunk hPSC-Derived Neural Crest but Not the Cranial-Trunk Decision
    James O.S. Hackland, Patrick B. Shelar, Nabjot Sandhu, Maneeshi S. Prasad, Rebekah M. Charney, Gustavo A. Gomez, Thomas J.R. Frith, Martín I. García‐Castro · 2019 · Stem Cell Reports
87. Physiological and Pathological Ageing of Astrocytes in the Human Brain
    Marloes Verkerke, Elly M. Hol, Jinte Middeldorp · 2021 · Neurochemical Research
88. Klotho inhibits neuronal senescence in human brain organoids
    Mohammed R. Shaker, Julio Aguado, Harman Kaur Chaggar, Ernst Jurgen Wolvetang · 2021 · npj Aging and Mechanisms of Disease
89. Cellular reprogramming as a tool to model human aging in a dish
    Patrícia R. Pitrez, Luís Miguel Monteiro, Oliver Borgogno, Xavier Nissan, Jérôme Mertens, Lino Ferreira · 2024 · Nature Communications
90. iPSCs: On the Road to Reprogramming Aging
    Clara Soria‐Valles, Carlos López-Otı́n · 2016 · Trends in Molecular Medicine
91. Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: Concise Review
    Ana Artero‐Castro, Francisco Javier Rodríguez Jimenez, Pavla Jendelová, Slaven Erceg · 2019 · Stem Cells
92. A Simple Differentiation Protocol for Generation of Induced Pluripotent Stem Cell-Derived Basal Forebrain-Like Cholinergic Neurons for Alzheimer’s Disease and Frontotemporal Dementia Disease Modeling
    Sonia Sanz Muñoz, Martin Engel, Rachelle Balez, Dzung Do‐Ha, Mauricio Castro Cabral-da-Silva, Damián Hernández, Tracey Berg, Jennifer A. Fifita, Natalie Grima, Shu Yang et al. · 2020 · Cells
93. Retinal Organoids: A Next-Generation Platform for High-Throughput Drug Discovery
    Hongkun Zhao, Fei Yan · 2023 · Stem Cell Reviews and Reports
94. Synaptic plasticity in human thalamocortical assembloids
    Mary H. Patton, Kristen T. Thomas, Ildar T. Bayazitov, Kyle D. Newman, Nathan B. Kurtz, Camenzind G. Robinson, Cody A. Ramirez, Alexandra J. Trevisan, Jay B. Bikoff, Sam Peters et al. · 2024 · Cell Reports
95. REPROGRAMMING PATIENT-DERIVED CELLS TO STUDY THE EPILEPIES
    J. Parent, Stewart A. Anderson · 2015 · Nature Neuroscience
96. Advances and Current Challenges Associated with the Use of Human Induced Pluripotent Stem Cells in Modeling Neurodegenerative Disease
    Bonnie J. Berry, Alec S.T. Smith, Jessica E. Young, David L. Mack · 2018 · Cells Tissues Organs
97. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery
    Qian Lu, Julia TCW · 2021 · International Journal of Molecular Sciences
98. Spatial RNA Sequencing Identifies Robust Markers of Vulnerable and Resistant Human Midbrain Dopamine Neurons and Their Expression in Parkinson’s Disease
    Julio Aguila Benitez, Shangli Cheng, Nigel Kee, Ming Cao, Menghan Wang, Qiaolin Deng, Eva Hedlund · 2021 · Frontiers in Molecular Neuroscience
99. Human Stem Cell-Derived Astrocytes: Specification and Relevance for Neurological Disorders
    Giulia E. Tyzack, András Lakatos, Rickie Patani · 2016 · Current Stem Cell Reports
100. Using Patient-Derived Induced Pluripotent Stem Cells to Identify Parkinson’s Disease-Relevant Phenotypes
     Samantha L. Sison, Scott Vermilyea, Marina Elena Emborg, Allison D. Ebert · 2018 · Current Neurology and Neuroscience Reports